For the largest pin badge sentence ‘Pride of India’, Glenmark Pharmaceuticals successfully achieved a world record on 18 August in Mumbai. This achievement is aimed to honour the healthcare warriors, who have been on the frontlines of the nation’s battle against COVID-19, safeguarding countrymen’s lives whilst risking theirs.
A total of 22,373 Indian flag pin badges were used to create the sentence. Over 15,000 diabetologists, cardiologists and physicians from across the country participated and supported this unique initiative honouring the frontline warriors.
In the Diabetes Care segment in India, Glenmark Pharmaceuticals is a pioneer and it is the first company in the world to launch its patent-protected and globally-researched sodium glucose co-transporter-2 (SGLT2) inhibitor Remogliflozin etabonate by the brand names Remozen. It has launched multiple brand extensions like Remozen-M, Remozen V in the market. With its Favipiravir brand FabiFlu, Glenmark has also been at the forefront in the country’s fight against COVID-19.
